Cargando…

Correlation between the overexpression of epidermal growth factor receptor and mesenchymal makers in endometrial carcinoma

OBJECTIVE: The objective of this study was to evaluate the effect of overexpression of epidermal growth factor receptor (EGFR) on the expression of epithelial cell markers (E-cadherin and α-catenin) and mesenchymal cell markers (N-cadherin and vimentin) in endometrial carcinoma. METHODS: The express...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Wei-Ning, Ai, Zhi-Hong, Wang, Juan, Xu, Yan-Li, Teng, Yin-Cheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology 2014
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3893673/ https://www.ncbi.nlm.nih.gov/pubmed/24459579 http://dx.doi.org/10.3802/jgo.2014.25.1.36

Ejemplares similares

Human epidermal growth factor receptor-2 overexpression and amplification in metastatic and recurrent high grade or type 2 endometrial carcinomas
por: Kato, Rina, et al.
Publicado: (2013)

Activation of epidermal growth factor receptor results in Snail protein but not mRNA overexpression in endometrial cancer
por: Hipp, Susanne, et al.
Publicado: (2009)

Overexpression of the Insulin Receptor Isoform A Promotes Endometrial Carcinoma Cell Growth
por: Wang, Chun-Fang, et al.
Publicado: (2013)

Ligand-Independent Epidermal Growth Factor Receptor Overexpression Correlates with Poor Prognosis in Colorectal Cancer
por: Yun, Sumi, et al.
Publicado: (2018)

Retraction: Overexpression of the Insulin Receptor Isoform A Promotes Endometrial Carcinoma Cell Growth
Publicado: (2021)

p53 mutation and epidermal growth factor receptor overexpression in glioblastoma.
por: Yoon, K. S., et al.
Publicado: (2001)

Correlation between the overexpression of epidermal growth factor receptor and pathological features of gastric cancer: a meta-analysis
por: Cui, Fan, et al.
Publicado: (2021)

Detection of human epidermal growth factor receptor 2 overexpression in canine anal sac gland carcinoma
por: YOSHIMOTO, Sho, et al.
Publicado: (2019)

Nuclear Epidermal Growth Factor Receptor Overexpression as a Survival Predictor in Oral Squamous Cell Carcinoma
por: Tarle, Marko, et al.
Publicado: (2023)

Immunohistochemical Expression of BCL-2 in Endometrial Carcinoma and Its Comparison With Hormone Receptor Status and Epidermal Growth Factor
por: Kandaswamy, Sharanya, et al.
Publicado: (2023)

The Epidermal Growth Factor Receptor Critically Regulates Endometrial Function during Early Pregnancy
por: Large, Michael J., et al.
Publicado: (2014)

Overexpression of Epidermal Growth Factor Receptor (EGFR) and HER-2 in Bladder Carcinoma and Its Association with Patients’ Clinical Features
por: Li, Wei, et al.
Publicado: (2018)

Overexpression of human epidermal growth factor receptor 2 in canine primary lung cancer
por: YOSHIMOTO, Sho, et al.
Publicado: (2020)

Cortactin overexpression results in sustained epidermal growth factor receptor signaling by preventing ligand-induced receptor degradation in human carcinoma cells
por: van Rossum, Agnes GSH, et al.
Publicado: (2005)

Human epidermal growth factor receptor 2/neu overexpression in urothelial carcinoma of the bladder and its prognostic significance: Is it worth hype?
por: Kumar, Santosh, et al.
Publicado: (2015)

Human epidermal growth factor receptor 2 (Her2) testing for uterine serous carcinoma: Report of scenarios of unusual overexpression
por: Quddus, M. Ruhul, et al.
Publicado: (2020)

Tumourigenic multidrug-resistant HT1080 cells do not overexpress receptors for epidermal growth factor.
por: Slovak, M. L., et al.
Publicado: (1991)

Human Epidermal Growth Factor Receptor 2 (HER2) in Cancers: Overexpression and Therapeutic Implications
por: Iqbal, Nida, et al.
Publicado: (2014)

The insulin-like growth factor I receptor is overexpressed in psoriatic epidermis, but is differentially regulated from the epidermal growth factor receptor
Publicado: (1992)

Human epidermal growth factor receptor 2 targeted therapy in endometrial cancer: Clinical and pathological perspectives
por: Saito, Ayumi, et al.
Publicado: (2021)

TMEM41A overexpression correlates with poor prognosis and immune alterations in patients with endometrial carcinoma
por: Shi, Ke, et al.
Publicado: (2023)

Endometrial epidermal growth factor profile and its abnormalities in dairy cows
por: KATAGIRI, Seiji, et al.
Publicado: (2016)

Expression of transforming growth factor alpha, epidermal growth factor receptor and epidermal growth factor in precursor lesions to gastric carcinoma.
por: Filipe, M. I., et al.
Publicado: (1995)

Loss of epidermal growth factor receptor expression in oral squamous cell carcinoma is associated with invasiveness and epithelial-mesenchymal transition
por: KIMURA, IYO, et al.
Publicado: (2016)

Role of Epidermal Growth Factor Receptor-Specific CAR-T Cells in the Suppression of Esophageal Squamous Cell Carcinoma
por: Cheng, Chen, et al.
Publicado: (2022)

Prognostic Impact of Epidermal Growth Factor Receptor Overexpression in Patients with Cervical Cancer: A Meta-Analysis
por: Tian, Wei-Jie, et al.
Publicado: (2016)

A study of human epidermal growth factor receptor 2 overexpression by immunohistochemistry in patients with gastric adenocarcinoma
por: ABOOD, RAFID A., et al.
Publicado: (2023)

TRP channel expression correlates with the epithelial–mesenchymal transition and high-risk endometrial carcinoma
por: Van den Eynde, Charlotte, et al.
Publicado: (2021)

Epidermal Overexpression of Xenobiotic Receptor PXR Impairs the Epidermal Barrier and Triggers Th2 Immune Response
por: Elentner, Andreas, et al.
Publicado: (2017)

Larotinib in patients with advanced and previously treated esophageal squamous cell carcinoma with epidermal growth factor receptor overexpression or amplification: an open-label, multicenter phase 1b study
por: Liu, Rongrui, et al.
Publicado: (2021)

Targeting Tumor Cells Overexpressing the Human Epidermal Growth Factor Receptor 3 with Potent Drug Conjugates Based on Affibody Molecules
por: Rinne, Sara S., et al.
Publicado: (2022)

The putative Tumor Suppressor VILIP-1 Counteracts Epidermal Growth Factor-Induced Epidermal-Mesenchymal Transition in Squamous Carcinoma Cells
por: Schönrath, Katharina, et al.
Publicado: (2012)

The Role of Epidermal Growth Factor Receptor Mutations and Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in the Treatment of Lung Cancer
por: Chang, Shih-Chieh, et al.
Publicado: (2011)

Overexpression of Nucleolin is a Potential Prognostic Marker in Endometrial Carcinoma
por: Lin, Qianhan, et al.
Publicado: (2021)

Overexpression of epidermal growth factor receptor as a prognostic factor in colorectal cancer on the basis of the Allred scoring system
por: Rokita, Marta, et al.
Publicado: (2013)

Patritumab plus trastuzumab and paclitaxel in human epidermal growth factor receptor 2‐overexpressing metastatic breast cancer
por: Mukai, Hirofumi, et al.
Publicado: (2016)

Poly-Lysine Dendritic Nanocarrier to Target Epidermal Growth Factor Receptor Overexpressed Breast Cancer for Methotrexate Delivery
por: Narayanan, Pratibha, et al.
Publicado: (2022)

Effect of human epidermal growth factor receptor 2 overexpression in metastatic colorectal cancer on standard chemotherapy outcomes
por: Jang, Jae Yeon, et al.
Publicado: (2023)

Androgen receptor expression in endometrial carcinoma and its correlation with clinicopathologic features
por: Hashmi, Atif Ali, et al.
Publicado: (2018)

Immunohistochemical detection of epidermal growth factor receptors on human colonic carcinomas.
por: Steele, R. J., et al.
Publicado: (1990)

Cannot write session to /tmp/vufind_sessions/sess_u5obkn50dq69cnmr1gkutl6fm2